Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers
breadcrum image


Immunohistochemistry (IHC) - CD5 is a diagnostic test used in pathology labs to help classify various types of lymphomas and leukemias. The CD5 marker is often expressed on the surface of certain immune cells like T cells and a subset of B cells. Its presence or absence can help in diagnosing specific types of lymphomas and leukemias.

This test uses antibodies designed to detect the presence of the CD5 protein in tissue samples. If the protein is present, the antibodies bind to it, allowing for its visualization under a microscope. CD5 plays a critical role in the activation and differentiation of T cells, which are crucial components of our immune system.

The test is performed on a biopsy sample, which can be obtained from any part of the body where the suspected lymphoma or leukemia is present. This test doesn't require any specific preparation like fasting or restriction of certain medications. However, patients should always inform their doctor about their medical history and the medications they're currently taking.

  • Test NameIHC - CD5
  • Sample TypeTissue
  • Preparations RequiredNone
  • Report Time3 days

Why is the IHC - CD5 test important?

The IHC - CD5 test is crucial for the diagnosis and classification of certain types of lymphomas and leukemias. It helps in understanding the type of immune cells involved in the disease, which aids in determining the most effective treatment approach.

How is the test performed?

A biopsy is taken from the patient, and the sample is sent to the lab. It is then processed and stained with antibodies that bind to CD5 if present. The stained sample is observed under a microscope to assess the presence of CD5.

Home Sample Collection Process

Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

No, this test does not require fasting.

A positive result indicates the presence of the CD5 protein in the cells, suggesting the involvement of certain types of immune cells in the disease.

The frequency of this test depends on the clinical condition of the patient and the doctor's recommendation. It is typically performed at the time of diagnosis.

There are no specific precautions to take before this test. However, you should inform your doctor about any medications you are currently taking.

An abnormal test result should be discussed with a hematologist or oncologist, specialists in treating blood diseases and cancers.

The quality of the tissue sample and the accuracy of the staining and visualization process can affect the result.

In a normal immune system, CD5 is present on all T cells and a subset of B cells. However, its presence or absence in a tissue sample depends on the specific disease condition being investigated.

Factors affecting the levels of CD5 include the type and stage of the disease, the patient's overall health, and response to therapy, if already initiated.

No specific preparation is required for this test.

No, this test requires a tissue biopsy and specialized equipment and expertise to be performed and interpreted. It cannot be done at home.

The pain associated with the IHC - CD5 test is primarily related to the biopsy procedure used to obtain the tissue sample. Depending on the location from which the sample is taken, you may feel some discomfort or pain. However, local or general anesthesia is typically used to minimize any discomfort.

This test can be performed during pregnancy if the healthcare provider deems it necessary. However, the biopsy procedure should be done with care to avoid any risks to the mother or the baby.

Yes, children can undergo this test if they are suspected of having a disease that requires the examination of the CD5 protein. The biopsy procedure, however, should be performed under the guidance of a pediatrician.

As with any biopsy procedure, there are some risks associated, such as bleeding, infection, or an adverse reaction to anesthesia. Your healthcare provider will discuss these risks with you and take necessary precautions.

Medications do not generally affect the results of the IHC - CD5 test. However, it's always a good idea to inform your healthcare provider of any medications you're taking.

No, the IHC - CD5 test does not involve exposure to radiation.

The IHC - CD5 test is a specific type of immunohistochemistry test that is useful in identifying certain types of lymphomas and leukemias. A doctor may order this test when they suspect these specific conditions and want to confirm the diagnosis and understand the disease better.

Abnormal results can indicate a medical condition that needs to be addressed. Depending on the results, your healthcare provider may suggest additional tests or treatment options.

In conclusion, the IHC - CD5 test is an important tool in the diagnosis and management of certain types of lymphomas and leukemias. This test, along with other clinical evaluations, allows healthcare providers to devise the most effective treatment strategies for their patients. It's essential to discuss the implications of the test results with your healthcare provider for a comprehensive understanding of your health condition.

Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet